tbuckley/cabot-search huggingface dataset:
Lymphangiography in Chyluria
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Prenatal exposure to acid suppressant medications and the risk of recurrent wheeze at 3 years of age in children with a history of severe bronchiolitis
Authors: Lacey B. Robinson, Anna J. Chen Arroyo, Marina A.S. Dantas, Janice A. Espinola, Ashley F. Sullivan, Carlos A. Camargo
Journal: Journal of Allergy and Clinical Immunology (2019)
Probiotics Revisited
Journal: JAMA (2014)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Scandinavian Journal Clin &amp;amp; Lab Invest, Oslo
Journal: JAMA (1964)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Four uncommon infections in Hodgkin's disease
Authors: M. L. Goodman
Journal: JAMA (1966)

<h3>To the Editor:</h3> Bacterial, fungal, protozoal, and virus infections develop as examples of altered immunity in patients with malignant lymphomas of the Hodgkin's disease type. A patient with Hodgkin's disease died with herpetic esophagitis, toxoplasmosis of lung and stomach, cytomegalic inclusion disease of lung, and sarcocystis infection of the heart. A 64-year-old white woman was admitted to the University Hospital with a nonproductive cough of two months' duration, weight loss, and fatigue. Physical examination showed hepatosplenomegaly without peripheral lymphadenopathy. Hemoglobin was 10.2 gm/100 ml; hematocrit, 31%; white blood cell count, 6,700/cu mm, with 82% neutrophils. Chest x-ray examination showed faint, rounded densities in the left lower lung field, and laminograms of the chest showed discrete nodular densities in the lower lobes of the lungs. Radiographic films of the abdomen demonstrated hepatic and splenic enlargements. At surgical exploration for acute and chronic cholecystitis and cholelithiasis, the gallbladder was excised, and liver
An Introduction to Malariology.
Journal: JAMA (1931)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation
Authors: P SHEINER
Journal: Hepatology (1995)

Recurrent hepatitis C causes significant morbidity after liver transplantation. Because immunosuppression is associated with enhanced viral replication, we postulated that clinical recurrence of the disease may be associated with augmented immunosuppression for rejection. In 96 patients with hepatitis C who received liver transplants, we recorded the interval from transplantation to recurrence, the episodes of steroid-resistant rejection (SRR) requiring OKT3, the number of rejection episodes, and the use of OKT3 induction. Recurrence was diagnosed based on elevated transaminases and characteristic histology. Hepatitis C recurred in 43 of 96 patients. Fifteen of 21 patients (71.4%) who previously had SRR hadrecurrence, versus 28 of 75 patients (37.3%) who either had no SRR (72 patients) or had it after recurrence was diagnosed (3 patients) (P <.01). Mean time to recurrence was 127 ± 31 days in the 15 patients who had had SRR versus 246 ± 42 days in the other 28 patients (P = 0.02). Recurrence and number of rejection episodes were clearly associated: 6 of 33 patients (18.2%) with no rejection had recurrence (P<.05), versus 11 of 26 patients (42.3%) with one rejection episode (P<.05) and 26 of 37 (70.2%) with more than 1 episode (P<.05). OKT3 induction was used in 15 patients; 9 of 15 patients had recurrence (ns) at 337 ± 95 days. Of 72 patients who initially received triple immunosuppression, 30 patients had recurrence at 186 ± 25 days (P = 0.05). Nine patients received primary FK506; 4 had recurrence at 68 ± 14 days. SRR requiring OKT3 is associated with a higher incidence and earlier presentation of recurrent hepatitis C. Multiple rejection episodes are also associated with a higher recurrence rate. Induction immunotherapy, by reducing the rate of early rejection, may delay the clinical recurrence of hepatitis C. (Hepatology 1995;21:30-34).
Influence of smoking and other environmental factors in inflammatory bowel disease activity: what do our patients think?
Authors: M. Thole, G. Erian, F. Jaboli, K. Greveson, O. Epstein, C. Murray, M. Hamilton, L. Marelli
Journal: Gut (2011)

<h3>Introduction</h3> It is widely accepted that smoking predisposes to Crohn9s disease (CD) but is protective against ulcerative colitis (UC). The precise impact of stress, the influence of diet and the efficacy of complementary medicines on the course of inflammatory bowel disease (IBD) are unclear (ECCO guidelines). The study aim was to assess our IBD patients9 knowledge about the association between IBD and smoking and to evaluate which factors they consider important in controlling bowel disease. <h3>Methods</h3> During a 6 weeks interval the authors prospectively recruited all patients attending the IBD clinic in our Institution. Patients were asked to complete an anonymous questionnaire which assessed basic demographics, smoking history and patient knowledge about their disease. Patients were asked to rank (in a scale from 0 to 10) the importance, in their opinion, of the following factors in controlling IBD activity: drugs, surgery, diet, stress control, stopping smoking and alternative therapy. <h3>Results</h3> The authors surveyed 199 patients (median age 44 years; M/F: 92/107) with IBD: 101 (51%) had CD, 86 (44%) had UC and 12 (5%) had IBD-unclassified. Median IBD duration was 12 years (range 1–60). 89% of CD patients were non-smoker compared to 95% of UC (p=0.015). 69% of CD patients reported to be aware of the negative association between smoking and CD; while only 36% of UC patients were aware of the positive association with UC. CD patients rated medications (mean value 7.8), followed by stress control (7.6) and even diet (7.4) as the most important factors able to influence their disease activity. Smoking cessation (7.0) and surgery (6.5) were considered less effective. Alternative treatment (3.6) was considered only marginally effective in IBD. There was a strong correlation between stress and diet (p&lt;0.001). Smoking correlated with stress (p&lt;0.002) and alternative therapy with diet (p&lt;0.001). UC patients gave rating similar to CD, except for smoking cessation (3.9). CD smokers considered stress (8.2) and diet (7.7) more important compared to CD non-smokers; while they rated smoking cessation (6.7) and surgery (4.2) less effective. <h3>Conclusion</h3> Only two thirds of CD patients recognise the importance of smoking cessation on disease activity, and one third of UC patients are aware of the positive association with smoking. IBD patients consider stress and diet as effective as drugs in controlling bowel disease; moreover, CD patients value stress and diet as more important than smoking in affecting disease activity. Clinicians should always consider the perceptions and beliefs of the patient when discussing treatment strategy in IBD.
The esophageal obturator airway
Authors: T. A. Don Michael
Journal: JAMA (1984)

<h3>In Reply.—</h3> We agree with Dr Don Michael that the study by Schofferman et al<sup>1</sup>is inadequate to evaluate the EOA. This study was performed in a controlled situation under physician direction in the emergency room. Consequently, the report did not evaluate the capability of the EOA for prehospital ventilation. Two studies have documented that prehospital ventilation with the EOA, as measured by arterial blood gases, is inadequate.<sup>2,3</sup> One study used EMT II rescuers and the other paramedics, so training of rescuers does not appear to be important. Both studies indicated that difficulty in maintaining an effective mouth seal with the EOA contributed to the poor ventilatory results.<sup>2,3</sup> Facility of EOA insertion is a problem. The device offers little or no improvement over properly trained rescuers using endotracheal intubation. In a recent article inThe Journal, Jacobs et al reported that the endotracheal tube was successfully placed
The devil and William Dabney. An epidemiological postscript
Authors: F. J. Spencer
Journal: JAMA (1966)

On Tuesday, June 5, 1888, Dr. William C. Dabney, professor of obstetrics and practice of medicine in the University of Virginia, Charlottesville, saw the first recorded case of pleurodynia in North America.<sup>1</sup> [The patient] had been taken suddenly a few hours before with violent pain in the left side of the chest nearly over the region of the heart. His temperature was 103°, and the skin extremely hot and pungent to the touch; his bowels were rather constipated, but not markedly so; there was no nausea, but very little appetite. His chief complaint was of the pain in the chest, which was excruciating and aggravated by the slightest movement, or by drawing a long breath. Nothing abnormal could be discovered about the thoracic organs, however, on physical examination. Dr. Dabney prescribed rest, antipyrine, mercurous chloride, and a mustard plaster and made another visit the next day. The patient, a
Studies of the sudden infant death syndrome in King County, Washington. I. The role of viruses
Authors: C. G. Ray
Journal: JAMA (1970)

Since January 1965, a study of the sudden infant death syndrome (SIDS) in King County, Washington, has been conducted. Between August 1966 and June 1968, major changes in the protocol included the study of SIDS patients and controls as soon as possible after death, with extensive respiratory sampling, and strict avoidance of freezing of specimens before inoculation into tissue cultures. With use of this protocol, "significant" (nonpoliovirus) isolates were found in 37.5% of SIDS cases and in only 16.2% of controls. A diversity of serotypes was found. Viruses may have a significant role in the pathogenesis of SIDS, and some serotypes may have relatively greater importance than others. However, until the pathogenesis of this syndrome is more clearly defined, the relative significance of any single factor must remain speculative.
PREVENTION OF RABIES
Journal: JAMA (1952)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The value of advance care planning (ACP) in cancer critical care.
Authors: Diane G. Portman, Jeffrey E. Lancet, Hugo Francisco Fernandez, Sarah Thirlwell, Nancy Newman
Journal: Journal of Clinical Oncology (2015)

e20557 Background: Findings from previous research on the effect of advance directives (ADs) on patient outcomes have been mixed and are limited in the oncology population. A palliative care project in our Cancer Center’s ICU revealed patients with long lengths of stay (LOS) and ICU deaths without ADs in place. We sought to determine barriers associated with advance care planning in patients with advanced disease and the presence and effect of ADs on end-of-life cost of care (COC) and LOS in critical care patients at our Center. Methods: The 2013 COC and LOS of all ICU patients were compared to the subset of patients for whom ICU care proved futile, i.e., patients who expired in the ICU. The presence of ADs and DNR orders for expired ICU patients were matched to their respective COC, LOS, and cancer diagnosis. The COC of floor and ICU care were compared to determine potential cost savings from ICU avoidance. Medical oncologists and oncologic internists were surveyed to assess attitudes, perceptions, and barriers associated with advance care planning in patients with advanced disease. Results: Thirty-eight percent of ICU patients had ADs. Of those who expired in the ICU, 41% had an AD and the predominant cancer diagnoses were hematologic and thoracic malignancies. If an AD was present, it was most likely to be a Living Will (LW) with DNR. Living Wills (LW) with DNR were only obtained after longer lengths of stay. Without a DNR, the cost of care for patients with ADs was similar to that of patients with no AD. The daily weighted average COC was highest for patients without ADs and lowest for those with LWs with DNR, despite a longer LOS in this group. Expired Hematology and Thoracic ICU patients with LW/DNR had similar lower COC and lengthy LOS. Floor care cost on average $2,000 less per day than ICU care. A majority of providers surveyed indicated that having ADs should be a high priority and reported comfort with ACP for hospitalized patients, but not for outpatients. Conclusions: Obtaining timely ADs with DNR is likely to result in the lowest daily COC for critical patients. The greatest savings is likely to result from early ACP and ICU avoidance. Opportunities exist to better understand and overcome barriers to earlier outpatient implementation of ACP.
AMA Specialty Journal Abstracts
Journal: JAMA (1995)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Correction: The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation
Authors: Marka Crittenden, Brendan Curti, Walter J Urba, Roxanne Payne, Steven K Seung, Christopher B Fountain, ShuChing Chang, Jessica Fleser, Kimberly Phillips, Ian Malkasian, Lyn B Dobrunick
Journal: Journal for ImmunoTherapy of Cancer (2020)

on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation'
SportsMedUpdate
Authors: Martin P Schwellnus
Journal: British Journal of Sports Medicine (2010)

1. Kraemer R, 2. Knobloch K . A soccer-specific balance training programme for hamstring muscle and patellar and Achilles tendon injuries: an intervention study in premier league female soccer Am J Sports Med 2009;37:1384–93. [OpenUrl][1][Abstract/FREE Full Text][2] ### Background It has been documented that balance training can reduce the risk of some injuries (anterior cruciate ligament, ankle ligament sprains) in soccer players ### Research question/s Does a balance training programme reduce the incidence of hamstring muscle injuries and tendinopathy in elite female soccer players? ### Methodology Subjects: Twenty-four premier league female soccer players (21±4 years, body mass index 21.7±1.2). Experimental procedure: All the subjects were studied over three soccer seasons. In the first half of the first season, no intervention took place (CON period). Thereafter, subjects regularly performed specific balance training (12 exercises), and duration of balance training (min) was documented for two and a half seasons (TR period). In both periods, injuries (contact and non-contact) (injuries/1000 h of exposure and time lost/injury) were documented. Measures of outcome: Incidence of injuries (per 1000 h) in the two periods, mean time loss for injuries, correlation between duration of balance training and injury rate. ### Main finding/s The mean time loss of injuries (days) decreased from 14.4 (CON) to 1.5 (TR) (p=0.003), and there was a general relationship between increased training and reduction in injuries. ### Conclusion/s In a prospective cohort study over three seasons, a soccer-specific balance training programme in female players reduced the incidence of non-contact hamstring strain injuries, patellar tendinopathy and Achilles tendinopathy. Evidence-based rating: 7/10 … [1]: {openurl}?query=rft.jtitle%253DThe%2BAmerican%2BJournal%2Bof%2BSports%2BMedicine%26rft.stitle%253DAm%2BJ%2BSports%2BMed%26rft.issn%253D0363-5465%26rft.aulast%253DKraemer%26rft.auinit1%253DR.%26rft.volume%253D37%26rft.issue%253D7%26rft.spage%253D1384%26rft.epage%253D1393%26rft.atitle%253DA%2BSoccer-Specific%2BBalance%2BTraining%2BProgram%2Bfor%2BHamstring%2BMuscle%2Band%2BPatellar%2Band%2BAchilles%2BTendon%2BInjuries%253A%2BAn%2BIntervention%2BStudy%2Bin%2BPremier%2BLeague%2BFemale%2BSoccer%26rft_id%253Dinfo%253Adoi%252F10.1177%252F0363546509333012%26rft_id%253Dinfo%253Apmid%252F19567665%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [2]: /lookup/ijlink?linkType=ABST&journalCode=amjsports&resid=37/7/1384-a&atom=%2Fbjsports%2F44%2F12%2F908.atom